Dis-Chem Pharmacies Limited (JSE:DCP)
South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
2,442.00
-78.00 (-3.10%)
Nov 6, 2026, 5:09 PM SAST

Dis-Chem Pharmacies Cash Flow Statement

Millions ZAR. Fiscal year is Mar - Feb.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Net Income
894.57978.891,180984.481,000853.45
Depreciation & Amortization
1,2681,1541,079998.02941.15792.43
Other Amortization
106.06106.0666.6563.9260.9662.16
Loss (Gain) From Sale of Assets
-0.35-0.352.16-0.691.926.82
Loss (Gain) on Equity Investments
-48.18-48.18-20.21-45.27-22.78-1.19
Stock-Based Compensation
35.3435.3428.7524.2320.8218.58
Provision & Write-off of Bad Debts
3.543.545.581.634.796.54
Other Operating Activities
-80.14-37.82-40.8839.2431.2452.71
Change in Accounts Receivable
-497.46-497.46-590.41-148.49-374.61-186.77
Change in Inventory
-1.34-1.34-742.62-802.7-578.1866.43
Change in Accounts Payable
663.92663.92397.25712.36223.84115.94
Change in Other Net Operating Assets
-580.49-39.312.0463.4810.5849.05
Operating Cash Flow
1,7642,3171,3771,8901,3201,836
Operating Cash Flow Growth
-14.85%68.30%-27.17%43.20%-28.11%57.80%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Capital Expenditures
-1,356-1,104-1,402-1,027-1,090-377.27
Sale of Property, Plant & Equipment
22.1614.8837.1717.122.818.31
Cash Acquisitions
-221.22-212.48-155.94-55.18-43.53-265.75
Divestitures
-----1.19-
Investment in Securities
52.1229.3528.131.4521.21-160.85
Investing Cash Flow
-1,446-1,227-1,497-1,065-1,091-795.56

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Long-Term Debt Issued
-628.91,3721,2011,317536.53
Long-Term Debt Repaid
--1,541-1,525-1,329-1,491-941.66
Lease Payments
-722.02-691.99-641.17-586.62-565.36-510.1
Net Debt Issued (Repaid)
93.65-912.13-152.78-127.99-174.63-405.13
Repurchase of Common Stock
-60.23-60.43-32.6-65.49-28.53-12.17
Common Dividends Paid
-416.59-524.22-471.99-424.33-466.01-458.57
Other Financing Activities
-60-22.0110.75-14.03--27.31
Financing Cash Flow
-443.16-1,519-646.63-631.83-669.16-903.17

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Foreign Exchange Rate Adjustments
-2.7-5.461.44-0.24-1.177.62
Net Cash Flow
-128.81-434.68-765.51193.4-441.02145.04

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Free Cash Flow
407.591,213-25.46863.112301,459
Free Cash Flow Growth
-24.39%--275.26%-84.23%91.36%
Free Cash Flow Margin
0.92%2.83%-0.07%2.38%0.70%4.80%
Free Cash Flow Per Share
0.471.41-0.031.010.271.70
Levered Free Cash Flow
336.531,137-153.38725.14149.961,413
Unlevered Free Cash Flow
706.811,484172.241,017381.491,616
Free Cash Flow After Leases
-314.43521.35-666.63276.49-335.35948.78

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Feb '26 Feb '25 Feb '24 Feb '23 Feb '22
Cash Interest Paid
584.23559.64515.52457.38363.36330.96
Cash Income Tax Paid
378.77401.87430.65381.61381.31301.07
Change in Working Capital
-415.37125.82-923.75-175.35-718.3744.64